Expert Group Approves Safety, Efficacy of GSK’s Malaria Drug

Citing favorable clinical trial data, an FDA advisory committee voted Thursday in favor of the safety and efficacy of GlaxoSmithKline’s new drug application for tafenoquine indicated for radical cure and prevention of relapse of malaria.
Source: Drug Industry Daily